Oraquick zika point-of-care test
Ended Definitive Contract Awarded Last action
- Contract number
- HHSO100201600028C
- Awardee
-
Orasure Technologies Inc. UEI Y79RWFLHWDM6
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $4,969,093
Award facts
- Opportunity
-
- BAA16100SOL00001 Solicitation number
- Broad Agency Announcement (BAA) for Advanced Research and Development to Expedite the Identification, Development, and Manufacturing of Medical Countermeasures against Infectious Diseases Award Notice · Posted Oct 1, 2015
- Contract value 100% obligated
- $4,969,092.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Basic Research
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Fountain Hill, PA 18015, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$4,394,087 | |
| Other Administrative Action | -$263,645 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $2,612,925 | |
| Original award | $7,013,899 |
About this award
This federal contract award was made by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the Department of Health and Human Services (HHS), to Orasure Technologies Inc., a for-profit manufacturer of medical diagnostic products. The contract is for the development and production of the OraQuick Zika Point-of-Care Test, with a ceiling value of $4,969,092.67. The contract is a Definitive Contract with a Cost Plus Fixed Fee pricing type and an ultimate completion date of June 30, 2019. This contract does not have a set-aside designation, indicating it was awarded through full and open competition.
Orasure Technologies Inc., also known as Orasure, is a global company that specializes in the development, manufacture, and marketing of oral fluid diagnostic products and specimen collection devices. Through this and other federal contract awards, Orasure has provided a wide range of medical diagnostic products, including rapid tests for diseases such as HIV, Ebola, Hepatitis C, and COVID-19, as well as alcohol detection tests, to various government agencies. Orasure holds two significant indefinite delivery vehicles (IDVs) for supplying medical diagnostic products to federal agencies, with a potential value of $107.28 million from the Defense Logistics Agency Troop Support Medical and $6.38 million from the GSA Federal Supply Schedule 65-VII.
Quick answers
Who was awarded contract HHSO100201600028C?
HHSO100201600028C was awarded to Orasure Technologies Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on August 25, 2016.
How much is contract HHSO100201600028C worth?
The government has obligated $4,969,093 on HHSO100201600028C.
Was contract HHSO100201600028C competed?
The extent of competition for HHSO100201600028C was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award